Examiner: DEBERRY, REGINA M

Tech Center 1600 • Art Units: 1647 1677

This examiner grants 50% of resolved cases

Performance Statistics

50.0%

Allow Rate

-10.0% vs TC avg

635

Total Applications

+30.4%

Interview Lift

1237

Avg Prosecution Days

Based on 600 resolved cases, 2023–2026

2.2%

§101 Eligibility

18.6%

§102 Novelty

28.9%

§103 Obviousness

37.7%

§112 Clarity

App #	Title	Status	Assignee
19423385	INTRANASAL ADMINISTRATION OF NGF FOR THE PREVENTION OR TREATMENT OF RETINOPATHIES AND OPTIC NERVE DISORDERS	Final Rejection	Dompe` farmaceutici S.P.A.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.